medline.ch Respirationstrakt Neoplasie

	Economic value and clinical role of minimally invasive, biopsy-based diagnostics in non-small cell lung cancer. Cancer Cytopathol Guo J, Franzén B, Lewensohn R, Hysek M, Jönsson L. PMID: 42708823 [PubMed - indexed for MEDLINE]
	Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy. Pak J Pharm Sci Ju Z, Wu Y, Tian L, Shen D, Wang R. PMID: 42708777 [PubMed - indexed for MEDLINE]
	Environmental and occupational exposure in newly diagnosed lung cancer- data from the PROTEON study. Expert Rev Respir Med Sibille A, Hendrick J, Cue Alvarez A, Ernst M, Seidel L, Duysinx B, Louis R, Corhay JL. PMID: 42708503 [PubMed - as supplied by publisher]
	Identification of Causal Plasma Proteins and Immune Mediators for Lung Cancer in Never-Smokers: A Large-Scale Integrative Analysis Combining Mendelian Randomization, Colocalization, and Mediation. Curr Med Chem Wu JC, Zhang Q, Lin YM, Chen XR, Huang XB, Ye HY, Li J, Yang ZX, Wu QB, Su WM. PMID: 42708309 [PubMed - as supplied by publisher]
	The KEAP1-NFE2L2/NRF2 Axis in Non-Small Cell Lung Cancer Radioresistance: Redox Homeostasis and Emerging DNA Damage Response Mechanisms. Cancer Manag Res Jia X, Eerdemutu, Ren Y, Yang S, Yang C, Ding Q, Lin Y. PMID: 42708106 [PubMed]
	Family history of cancer and risk of lung cancer: a retrospective cohort study in a Chinese population. Front Med (Lausanne) Song H, Men X, Cheng J, Zhang L, Zhao S. PMID: 42707990 [PubMed]
	OLR1 as a Key Inflammatory Regulator Associated with Poor Response to Neoadjuvant Immunochemotherapy in Resectable Lung Cancer. J Inflamm Res Chen X, Zhang S, Ai X, Fan Y, Chen W. PMID: 42707646 [PubMed]
	Advances in understanding the mechanisms underlying acquired resistance to third-generation tyrosine kinase inhibitors in non-small cell lung cancer. Front Cell Dev Biol A-Lai GH, Li L, Ma G, Zhao YS, Yao P, Lin YD. PMID: 42707604 [PubMed]
	Mitochondrial niches of residual disease in EGFR-mutant NSCLC: immune-constrained persistence and therapeutic interception. Front Immunol Liang Z, Zhao X, Jiang M, Zhou M, Cheng M, Liu S, Zhao Y. PMID: 42707563 [PubMed - indexed for MEDLINE]
	Safety and quality of public chatbots for lung cancer prognostic information: a comparative evaluation. Front Public Health Jiang Y, Wang Q, Zheng L, Zhang L, Jiang B, Xu J, Wang J, Zhu J, Wu Z. PMID: 42707410 [PubMed - indexed for MEDLINE]
	Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer. Genes Chromosomes Cancer Köylü B, Genç N, Yücel MH, Y, A, K, Kemik F, Demir N, Bulutay P, Ölmez ÖF, Selçukbiricik F. PMID: 42706502 [PubMed - indexed for MEDLINE]
	Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer. Nat Commun Zhou F, Su C, Liang W, Xu LD, Tao W, Qian J, Xu S, Liu D, Fan R, Zhang Y, Liu Y, Wu L, Fu X, Zhang X, Shen N, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Chen W, He J, Zhou C. PMID: 42706268 [PubMed - indexed for MEDLINE]
	Unraveling lung cancer complexity: Spatial omics in tumor microenvironment characterization and precision medicine. Curr Probl Cancer Dasgupta S, Das S, Saha S. PMID: 42705130 [PubMed - as supplied by publisher]
	Efficacy and Safety of Savolitinib Plus Osimertinib in EGFR-Mutant, MET-Aberrant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Am J Clin Oncol Amir E, Khan MW, Mannan MS, Rayyan SM, Khan MAH, Saif H, Shahbaz H, Hussain SM, Khan H, Shahzaib M, Iqbal M, Javed A. PMID: 42704725 [PubMed - as supplied by publisher]
	Robot-assisted thoracoscopic fissureless fissure-last approach versus conventional interlobar method for left lower lobectomy in lung cancer: a comparative study of short-term outcomes. Gen Thorac Cardiovasc Surg Miyamoto T, Matsui S, Fujiwara W, Kidokoro Y, Kubouchi Y, Miwa K, Nakamura H, Tanaka Y. PMID: 42704591 [PubMed - as supplied by publisher]
	Prognostic Impact of Lymphovascular Invasion in Resected Pathological Stage I Invasive Non-small Cell Lung Cancer: A Propensity Score-Matched Cohort Study. Ann Surg Oncol Man L, Hao X, Zhang X, Cheng J, Xia L, Guo M, Xie Y, Cui R, Zhou W, Liu L. PMID: 42704565 [PubMed - as supplied by publisher]
	Artificial intelligence for lung cancer classification in cytology specimens: A systematic review and diagnostic test accuracy meta-analysis of benign-malignant diagnosis and ADC/SCC/SCLC subtyping. J Pathol Inform Myssayev A, Tamadon A, Mussin NM, Shirazi R, Zare A. PMID: 42703599 [PubMed]
	Integration of Histologic Pattern Classifiers and Graph Convolutional Networks for Prognostic Prediction in Lung Adenocarcinoma. JTO Clin Res Rep Yeh YC, Yu WH, Hsieh MS, Chang FP, Wang LC, Lu CW, Karla, Yu KH, Wu YC, Chen JS, Tsao MS, Yeh CY, Chou TY. PMID: 42703598 [PubMed]
	Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study. Drug Des Devel Ther Zhou J, Wang Y, Wen K, Huang C, Huang D, Qin T, Li M, Su Y, Sun Y, Chen P. PMID: 42703567 [PubMed - indexed for MEDLINE]
	Bronchial Artery Chemoembolization (BACE) Combined with PD-1 Blockade Versus Chemotherapy Combined with PD-1 Blockade for Non-Small Cell Lung Cancer in Older Adults. Clin Interv Aging Xiang J, Tu J, Gong W, Chen P, Wang Y, Li W, Zhong J, Ji J, Huang J. PMID: 42703541 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 162858

Seite 1 von 8143



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung